The Treatment Action Group’s 2014 Pipeline Report released in conjunction with the 20th International AIDS Conference last week devotes three sections to the outlook for better and more accessible treatment for hepatitis C, examining the promise of new direct acting antiviral treatments, starting with sofosbuvir (marketed by Gilead pharmaceutical company as Sovaldi) being eclipsed by […]
HIV
If the criteria for the selection announced Wednesday night of Vice President Mike Pence to lead the U.S. efforts to contain the spread of COVID-19 seemed […]
Tuberculosis
As a New Pandemic Spreads, World TB Day Reminds us of Unfinished Business – Efforts to fight the latest global health threat can come at the […]
Research & Development
This year marks the close of a dynamic decade in global infectious disease research and responses that changed expectations of what humanity can accomplish toward making […]
Policy
A coalition of medical, health care, health policy and other groups are calling on the United States Congress to swiftly and meaningfully fund emergency multifaceted domestic […]